MDRX Related Analyst Ratings
-
Wells Fargo Initiates Coverage on Allscripts-Misys Healthcare (MDRX) with an Outperform
-
Allscripts (MDRX) Falls as Raymond James Downgrades to Market Perform
-
Caris & Company Starts Allscripts-Misys (MDRX) at Above Average
-
Piper Jaffray Upgrades Allscripts-Misys (MDRX) to Overweight; Hearing of Large Contract Win
-
ThinkEquity Initiates Coverage on Allscripts-Misys Healthcare (MDRX) with an Acuumulate
-
Auriga Downgrades Allscripts-Misys (MDRX) to Hold; Valuation Call
-
Brean Murray Tells Investors To Capitalize On Recent Pullback In Allscripts-Misys (MDRX) Shares
-
Allscripts (MDRX) Shares Jump on Analyst Upgrade to Outperform
-
Leerink Swann Resumed Healthcare Technology and Distribution Sector With Positive Bias
-
Brean Murray Initiates Coverage on Allscripts-Misys Healthcare (MDRX)
-
Allscripts (MDRX) Gets Boost from JPMorgan Upgrade
-
Auriga Reiterates a 'Buy' on Allscripts-Misys (MDRX), Raises Price Target
-
Morgan Keegan Starts Allscripts-Misys (MDRX) at Outperform
-
Deutsche Bank Downgrades Allscripts-Misys (MDRX) to Sell
-
Auriga USA Reiterates a 'Buy' on Allscripts-Misys (MDRX), Raises Price Target to $12
-
UBS Downgrades Allscripts-Misys (MDRX) to Neutral
-
Leerink Swann Downgrades Allscripts-Misys (MDRX) to Market Perform
-
Raymond James Downgrades Allscripts (MDRX) to Market Perform
-
Piper Jaffray Downgrades Allscripts (MDRX) to Neutral
-
Matrix USA Rating Changes 8/27
-
Raymond James Downgrades Allscripts (MDRX) to Market Perform
-
Cramer Sees Allscripts (MDRX) Moving 44% Higher
-
Allscripts (MDRX) Recommended By Jim Cramer
-
JMP Starts Allscripts (MDRX) at Market Perform
-
Matrix USA Rating Changes 5/20
-
Thomas Weisel Upgrades Allscripts (MDRX) to Overweight
-
Raymond James Upgrades Allscripts (MDRX) to Strong Buy
-
Matrix USA Rating Changes 2/29
-
UBS upgrades Allscripts (MDRX) to Buy
-
Raymond James Downgrades Allscripts (MDRX) to Market Perform
-
Deutsche Bank Downgrades Allscripts (MDRX) to Hold; Cuts PT to $15.50
-
Merrill Lynch Starts Allscrips (MDRX) at Neutral
-
Piper Jaffray Adds Allscripts (MDRX) to Alpha List
-
UBS upgrades Allscripts Healthcare Solutions (MDRX) to Neutral
-
Needham Downgrades Allscripts (MDRX) to Hold
-
First Analysis Initiates Coverage on Allscripts (MDRX) with an Overweight
-
Raymond James Starts Allscripts (MDRX) at Strong Buy
-
BB&T Capital downgrades Allscripts (MDRX) to Hold
-
Stifel Nicolaus Initiates Coverage on Allscripts Healthcare (MDRX) with a Buy
-
JMP Securities Upgrades Allscripts Healthcare Solutions (MDRX) to Strong Buy
-
CIBC Starts Allscripts Healthcare Solutions (MDRX) at Sector Performer
-
Thomas Weisel downgrades Allscripts Healthcare Solutions (MDRX) to Market Weight
-
Caris & Co Upgrades Allscripts (MDRX) to Above Average
-
Prudential Starts Allscripts Healthcare (MDRX) at Overweight
-
Deutsche Bank Starts Allscripts (MDRX) at Buy
-
UBS downgrades Allscripts (MDRX) to Reduce
-
BB&T Capital Starts Allscripts Healthcare Solutions (MDRX) at Buy
-
UBS Starts Allscripts (MDRX) at Neutral
-
Thomas Weisel Initiates Coverage Allscripts (Nasdaq: MDRX) with an Outperform
-
Goldman Sachs Starts Allscripts Healthcare (MDRX) at In-Line
Back to MDRX Stock Lookup
